What every doctor should know about HIV - Miscellaneous Gram positive material (links 195-236)

Web-based references relating to the number under the disk sign, listed by page header


What every doctor should know about HIV
195 Internat. aids soc & uk 1997 Guidelines"see P Easterbrook 1997 bmj ii 557; page 400

196 Link not available; page 401

197 Link not available; page 401

198 Reservoirs, sanctuaries, and residual disease: the hiding spots of HIV-1.; page Pomerantz RJ. HIV Clin Trials ; 4:137-43. [Link]; page 401

199 NEJM 2004M Greenberg. Resistence to enfuvirtide; page [Link]; page 401

200 The Lancet 2005; 366:549-555. DOI:10.1016/S0140-6736(05)67098-5. Depletion of latent HIV-1 infection in vivo: a proof-of-concept study. Ginger Lehrman [Link]; page 401

201 Link not available; page 401

202 Link not available; page 401

203 Total lymphocyte counts and ART in resource-limited settings. D Moore 2006 Lancet 366 1831. [Link]; page 401

(footnote) Current issues in the prevention of mother-to-child transmission of HIV-1 infection. Author: Newell ML. Journal: Trans R Soc Trop Med Hyg; 2006 Jan ; 100(1):1-5. PubMed ID: 16214193 [Link]; page 400

Antiretroviral agents
204 Link not available; page 402

205 Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV. Author: Gallant JE, DeJesus E, Arribas JR, Pozniak AL, Gazzard B, Campo RE, Lu B, McColl D, Chuck S, Enejosa J, Toole JJ, Cheng AK, Study 934 Group . Journal: N Engl J Med; 2006 Jan 19 ; 354(3):251-60. PubMed ID: 16421366. [Link]; page 402

206 Guidelines on when to start HIV therapy are constantly changing .For latest information, see British HIV Association (BHIVA) guidelines. www.bhiva.org; page 402

207 Recommended therapy is constantly changing. For the latest recommended combinations of antiretrovirals, see the latest British National Fomulary www.bnf.org; page 402

208 Emtricitabine, a New Antiretroviral Agent with Activity against HIV and Hepatitis B Virus. Author: Saag MS. Journal: Clin Infect Dis; 2006 Jan 1 ; 42(1):126-31. PubMed ID: 16323102. [Link]; page 402

209 S Walmsley 2002 NEJM 346:2039 [Link]?; page 402

210 S Piscitelli 2001 NEJM 344: 984 [Link]?; page 402

211 RJC Gilson 2001 BMJ 322:1160-1164 [Link]; page 402

212 Online HIV textbook: HIV medicine; Christian Hoffmann et al. 2005 [Link]; page 403

213 Treatment strategies for highly treatment-experienced HIV-infected patients. Author: Luber AD. Journal: Expert Rev Anti Infect Ther; 2005 Oct ; 3(5):815-23. PubMed ID: 16207173. [Link]; page 403

214 Simplification therapy with once-daily didanosine, tenofovir and efavirenz in HIV-1-infected adults with viral suppression receiving a more complex antiretroviral regimen: final results of the EFADITE trial. Author: Barrios A, Negredo E, Domingo P, Estrada V, Labarga P, Asensi V, Morales D, Santos J, Clotet B, Soriano V, EFADITE Study Group . Journal: Antivir Ther; 2005 ; 10(7):825-32. PubMed ID: 16312178. [Link]; page 403

215 Lancet 2005 ; Maintaining anti-AIDS commitment post '3 by 5'. Nov 26 366 205 [Link]; page 403

216 BBC item: Kenya struggles to combat HIV [Link]; page 403

217 Lancet 2005 p 891 &: A prospective survey of the outcome of pregnancy in a rural area of the Gambia. Author: Greenwood AM, Greenwood BM, Bradley AK, Williams K, Shenton FC, Tulloch S, Bypass P, Oldfield FS. Journal: Bull World Health Organ; 1987 ; 65(5):635-43. PubMed ID: 3501343 [Link]; page 403

Sexually transmitted infections/diseases (STI/STD)
218 Health protection agency [Link]; page 404

219 D Scholes 1996 NEJM 334:1362; page 404

220 Link not available; page 404

221 Lymphogranuloma venereum proctitis: An emerging sexually transmitted disease in HIV-positive men in the Netherlands. Author: Perenboom RM. Journal: Drugs Today (Barc); 2006 Mar ; 42 Suppl A():43-5. PubMed ID: 16683043. [Link]; page 404

222 Link not available; page 405

223 Health Protection Agency [Link]; page 405

224 Final draft review 2 (Chlamydial infection screening) [Link]; page 405

Vaginal discharge and urethritis
225 Image of Trichomonas vaginalis courtesy of Prof S Upton, Kansas University [Link]; page 406

226 An Atlas of Bedside Microscopy; JM Longmore RGGP; page [Link]; page 406

227 Ciprofloxacin resistance in Neisseria gonorrhoeae in England and Wales in 2002. Author: Fenton KA, Ison C, Johnson AP, Rudd E, Soltani M, Martin I, Nichols T, Livermore DM, GRASP collaboration . Journal: Lancet; 2003 May 31 ; 361(9372):1867-9. PubMed ID: 12788575. [Link]; page 407

Miscellaneous Gram positive material
228 One study in Chicargo fount time in hospital increased by 3-fold (to 14.3 days); death rate 11% [No Link: LT 9/8/2005 20]; page 408

229 Link not available; page 408

230 Image of streptococcal lymphangitis in a diabetic patient courtesy of Prof David Handley [Link]; page 408

231 Supplied by Prof RL Vollum to Churchill, and thence USA, thence Iraq [batch 14578] [No link--see The Times for Aug 9th 2005 p19 col 1]; page 409

232 S Antoniu 2000 Lancet 356 664; page 409

233 S Tabaqchali 1997 Lancet 350 1644; page 409

234 Dose not in bnf, see N Beeching Infectious Diseases 1994 Wolfe; page 409

235 Increased reports of suspected cases of wound botulism among injecting drug users during 2004. Current Issue: Volume 15 Number 27 Published on: 7 July 2005 [Link]; page 409

236 F Charlton 1994 bmj i 1060; page 409

(footnote) S Chang 2003 NEJM 348 1342 [?no link]; page 408